TC Heartland & Hatch-Waxman: The Sky's Not Falling

By John Kennedy (June 9, 2017, 1:24 PM EDT) -- The U.S. Supreme Court's recent TC Heartland decision is poised to shake up patent litigation across the country, but the process for suing over abbreviated new drug applications and biosimilars under the Hatch-Waxman Act will likely remain undisrupted and keep cases in the usual venues, experts say....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!